KPL
NSE#831 by turnoverKwality Pharmaceuticals Limited
Key statistics
- Open
- ₹3,667.80
- Day range
- 3,639.00 – 3,774.40
- 52-week range
- —
- From 52w high
- —
- Volume
- 32.2K
- Turnover
- ₹11.8Cr
- Delivery
- 38.6%
- Rel volume
- 0.66×
- RSI (14)
- 58.2
- ATR (14)
- 205.19
- SMA 50
- 3,199.46
- SMA 200
- —
20-day avg 40.3%
Performance
- 1 day
- +0.83%
- 1 week
- +5.79%
- 1 month
- +10.41%
- 3 months
- +35.75%
- 6 months
- —
- 1 year
- —
Delivery percentage
- Latest
- 38.6%
- 20-day avg
- 40.3%
- 1-year avg
- 47.4%
- Percentile
- 20th
- Range
- 17.1–76.3%
25 Sept 2026
Against its own sessions
111 sessions
Over the last 20 sessions KPL settled 40.3% of its traded quantity, which is ordinary for an NSE equity. Its one-year average is 47.4%, so recent sessions are running 7.1 points lower than usual.
What delivery percentage measuresScan the whole market on delivery
Fundamentals
- Market cap
- ₹3,810 Cr
- P/E (TTM)
- —
- EPS (TTM)
- —
- Shares outstanding
- —
- Listed
- 20 Apr 2026
no positive TTM earnings
Classification
- Macro sector
- Healthcare
- Sector
- Healthcare
- Industry
- Pharmaceuticals & Biotechnology
- Basic industry
- Pharmaceuticals
NSE publishes no history for this taxonomy, so it is today’s classification rather than the one that held in the past.
Growth
- Revenue YoY
- —
- Profit YoY
- —
- Revenue QoQ
- —
- Profit QoQ
- —
- Interest cost YoY
- —
Compound growth
Not enough filed history for a compound growth rate yet.
Trailing-twelve-month figures against the same measure that many years earlier, on one reporting basis throughout. Blank where the filed history is too short or either end of the window was a loss — never a number built from less.
About
- ISIN
- INE552U01010
- Series
- EQ
- History from
- 20 Apr 2026
- Sessions
- 111
Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 25 Sept 2026.